Advocates of the proposal say it would prevent overdoses, slow the spread of HIV and inspire drug users to seek help, while proponents say safe injection sites would create an "open drug scene."
HIV remains a problem in the U.S. because people don't use life-saving prevention and treatments. COVID is heading down the same path. Here are insights from people fighting on the frontlines of HIV.
Findings from a new study help answer questions about why some people get more severe and transmissible HIV than others — and serve as a reminder that viruses don't always weaken over time.
The Food and Drug Administration this week approved an injectable drug that helps prevent the spread of HIV. It only has to be taken once every eight weeks, compared to a daily oral pill.
How did this new strain of the novel coronavirus evolve? Researchers are investigating various possibilities. One leading theory involves ... just one person.
Kenneth Kaunda spoke out about HIV when African leaders would not even acknowledge its existence. He sang about it, too, in a 2005 album that made a splash, then vanished. And so a search began.
Women in a Kenyan village had a radical idea to stop the practice of trading sex for fish to sell: What if they owned their own boats? They had great success. Then came a series of terrible setbacks.
As the first Black transgender woman to serve in this capacity, Tori Cooper says she is eager to advocate on behalf of all transgender and non-binary people living with HIV.
In rural Scott County, Ind., hundreds of people got HIV from sharing dirty needles. Now the syringe exchange widely credited with containing the outbreak is under political pressure to shut down.
Experts fear steep declines in testing and diagnoses mean more people will contract HIV and die of AIDS. The problem is particularly acute in the South, the epicenter of the nation's HIV crisis.
Syphilis cases in California have contributed to soaring national caseloads of sexually transmitted diseases. Experts point to the advent of dating apps, decreased condom use and an increase in meth.
People were dying of a disease that could be treated — but in poor countries, they did not have access to medicines that could help. That was the story of HIV — and now of COVID-19.
The administration is in its early days, but the infectious disease expert says he's encouraged by the new president's attitude about the pandemic. Science, Fauci says, is "going to rule."
The No. 1 and 2 causes of death remain the same, but there have been a number of notable changes. And now there's a new disease to assess on the global landscape: COVID-19.
The drugs only need to be taken a few times a year — and may soon be available in many parts of the world. Patients say they are more convenient and less stigmatizing.
The coronavirus pandemic feels eerily familiar to people who faced the AIDS crisis. It triggers memories of confusion over how the disease is transmitted and huge numbers of people dying quickly.
New Yorker writer Michael Specter covered Fauci's early work in the AIDS epidemic. "He's always taken an open-minded approach to the problems," Specter says of the infectious-disease expert.
As we find ourselves in the midst of a pandemic, Paul Lisicky's memoir is deeply affecting; we can recall the terror and frustration when no treatment or prevention was available for AIDS and HIV.
Fewer than a third of the 220 counties deemed by the federal government as vulnerable to similar outbreaks have active syringe exchange programs which can stop the spread of the infection.
In more than 30 states, it is illegal for someone with HIV to have sex without first disclosing their status. Some are now trying to change that, arguing that those laws endanger public health.
The topics range from a ticking time bomb in the Arctic to the art of taking selfies in an ethical way. Here are the stories selected by our contributors.
For people at high risk of HIV, taking a daily dose of a prevention drug is essential. But many can't afford it. A new federal program makes the drugs available for free.